All In MedTech

Device Trial Radar · NCT05631639

Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study

Last checked: Nov 20, 2026Latest source record: Nov 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

May 7, 2021

Primary completion

Jun 30, 2021

Study completion Aug 30, 2021

Sponsor

Lead sponsor
EnteraSense LimitedNot on our public-company list
Sponsor type
Industry
First posted
Nov 30, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, prospective, non-randomized, open-label, exploratory clinical investigation performed to evaluate safety and effectiveness of the PillSense System when used for detection of blood in the stomach of patients suspected to have an Upper Gastrointestinal Bleed (UGIB).

Conditions

  • Upper Gastrointestinal Bleeding

Interventions

  • PillSense SystemDevice

    The PillSense capsule is a diagnostic capsule equipped with a sensor for in vivo detection of liquid blood and a paired PillSense receiver for result display.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Device feasibilityTime frame: within 30 minutes

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Fakultní nemocnice Olomouc (FNOL)

    Olomouc, Czechia

  • Fakultní nemocnice Ostrava (FNO)

    Ostrava, Czechia

  • Institut klinické a experimentální medicíny (IKEM),

    Prague, Czechia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.